NBTXR3 Radiotherapy-Activated Functionalized Hafnium Oxide Nanoparticles Show Efficient Antitumor Effects Across a Large Panel of Human Cancer Models.
Ping ZhangJulie MarillAudrey DarmonNaeemunnisa Mohamed AnesaryBo LuSébastien ParisPublished in: International journal of nanomedicine (2021)
These data support that NBTXR3 could be universally used to treat solid cancers when radiotherapy is indicated, opening promising new therapeutic perspectives of treatment for the benefit of many patients.
Keyphrases
- end stage renal disease
- early stage
- oxide nanoparticles
- ejection fraction
- newly diagnosed
- endothelial cells
- radiation therapy
- chronic kidney disease
- locally advanced
- radiation induced
- quantum dots
- squamous cell carcinoma
- young adults
- electronic health record
- patient reported outcomes
- squamous cell
- high resolution
- induced pluripotent stem cells
- replacement therapy
- childhood cancer